000766 深市 通化金马

              通化金马药业集团股份有限公司

                  2023 年半年度财务报告

一、审计报告
半年度报告是否经过审计
□是 否
公司半年度财务报告未经审计。
二、财务报表
财务附注中报表的单位为：元
1、合并资产负债表
编制单位：通化金马药业集团股份有限公司

                                            2023 年 06 月 30 日

                                                                                                单位：元

              项目                        2023 年 6 月 30 日                    2023 年 1 月 1 日

 流动资产：

  货币资金                                            229,111,387.06                    336,821,630.18

  结算备付金

  拆出资金

  交易性金融资产                                          116,136.40                        128,392.00

  衍生金融资产

  应收票据                                                989,656.72                      4,279,924.04

  应收账款                                            436,538,415.65                    423,914,825.03

  应收款项融资                                          8,569,154.57                      42,229,783.05

  预付款项                                            12,559,475.54                      13,708,119.50

  应收保费

  应收分保账款

  应收分保合同准备金

  其他应收款                                          41,029,590.26                      35,751,024.25

    其中：应收利息

          应收股利

  买入返售金融资产

  存货                                                378,219,837.23                    381,372,601.42

  合同资产

  持有待售资产


  一年内到期的非流动资产

  其他流动资产                                            164,487.65                        164,487.65

流动资产合计                                        1,107,298,141.08                  1,238,370,787.12

非流动资产：

  发放贷款和垫款

  债权投资

  其他债权投资

  长期应收款

  长期股权投资                                        53,727,146.66                      56,426,182.76
……